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chrony. The MEG signatures and their analyses by statistical heat map-
ping, approaches pioneered by this laboratory, have allowed for the
separation of reported symptoms of GWI into distinct HLA and non-
HLA related domains. These ﬁndings lend further credence to an im-
mune/neuroimmune basis for the symptoms associated with GWI and
link themwith the concepts of exposure/genetic interactions. However,Gulf War Illness (GWI) is a complex multi-symptom disorder that
has proven elusive to understand and treat and it afﬂicts as many as a
quarter of the 700,000 soldiers deployed (Steele, 2000) to the Persian
Gulf in the 1991 war. These ill veterans were exposed to a number of
agents and conditions, but no speciﬁc sets of exposures can explain
the persistent symptoms (e.g. headaches, chronic fatigue, memory
loss, confusion, skin and gastrointestinal problems) and, not surprising-
ly, the pathophysiology of GWI has remained unclear (RAC, 2008).
However, recent examinations of ill veterans reveal a systemic immune
dysfunction that is exacerbated by physiological stress (Broderick et al.,
2013). Congruently, animalmodels nowexist that point to a heightened
neuroinﬂammation resulting from several Gulf War-relevant chemical
and physiological exposures (O'Callaghan et al., 2015). Neuroinﬂamma-
tion, the elaboration of proinﬂammatory cytokines and chemokines in
the CNS, is known to serve as an underlying cause of sickness behavior,
the features of which resemble those associated with GWI. Thus, a con-
vergence of animal and human data now point to a neuroimmune
mechanism underlying this disease.
While there is strong evidence suggesting that GWI is the result of
exposure to chemical toxicants during the war, there also have been
several studies suggesting that this illness is the result of an interaction
between exposures and genetics. A prior report in EBioMedicine by
Georgopoulos and colleagues (Georgopoulos et al., 2015) provided in-
sight into a basis for a genetic/immune role in GWI by showing that
higher counts for six Class II human leukocyte antigen (HLA) alleles con-
ferred protective effects in GWveterans based on lowered symptom se-
verity. In a recent follow-up from this group (Engdahl et al., 2016), a
difference in neural synchrony was found between ill and healthy GW
veterans. In an important extension of these ﬁndings in the current
issue, James et al. (2016) integrate these “neuro” and immune compo-
nents. Using analyses by magnetoencephalography (MEG), they show
that the HLA alleles have their action via modulation of neural signalingom.2016.10.019.
ss article under the CC BY-NC-ND licpatterns based on a sophisticatedmapping of brain regional neural syn-
the non-HLA related cluster also suggests that other mechanisms are at
play in the pathophysiology of GWI. The authors present ample specu-
lation as to the roles of both HLA and non-HLA-related factors relevant
to GWI, but also provoke many additional questions. For example,
what is the next step in understanding the meaning of these HLA and
non-HLA domains? Additionally, does the implied autoimmunemecha-
nism provide clear steps to pursue that will lead to treatable targets or
provide a path to the discovery of viable treatments for GWI?
As discussed in the commentary of the prior report (Georgopoulos et
al., 2015) provided by Wojcik and Lawrie (2015), illness results from
war, in general, and the number of studies evaluating the role of
stressors in GWI, as well as the implementation of programs to support
soldiers both pre- and post-deployment, highlights the impact that
stressors have on deployment-related disease. Previously, there has
been a tendency to label GWI as a psychological disorder (see discussion
by Steele, 2000; RAC, 2004). The overwhelming body of evidence has
ruled out a psychological/psychiatric basis of GWI (White et al., 2016)
and stressors in theater now are viewed as interacting with neurobio-
logical systems to contribute to GWI symptoms. As such, both human
and animal studies have suggested a connection between physiological
stress and the immune system, both systemically and in the brain. The
ﬁndings presented by James et al. (2016) support the notion that GWI
is a disease in which genetically-regulated sensitivity of the immune
system interacts with exposures that occurred in the GulfWar to repro-
gram neural functioning. The importance of such studies is highlighted
by the emphasis of the GulfWar Illness Research Programof theDepart-
ment of Defense's Congressionally DirectedMedical Research Programs
(CDMRP), where the need for research to address the role of neurolog-
ical and immune dysfunction, aswell as genetic predisposition in GWI is
a current priority. Not only does thework of James et al. (2016) address
all of these areas of interest, but it also supports the expansion of this
work into other relevant genetic/immune based studies. Such studies
are underway in animal models where genetically deﬁned strains of
mice, which combine a toxicologically susceptible mouse strain with a
more resistant strain (Jones et al., 2013) can be used to replicate a genet-
ically diverse population to evaluate genetic-based neuroimmune sus-
ceptibility to GWI. The combination of studies in both humans andense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
6 J.P. O'Callaghan et al. / EBioMedicine 13 (2016) 5–6animals can hopefully lead to a greater understanding of the cause of
GWI and the development of speciﬁc, targeted therapeutics to aid a
population of ill veteranswhohave beenwithout a successful treatment
for nearly three decades.
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